CE vs PRLD · rev $10.28B vs rev $6.5M
Celanese Corporation (CE) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CE currently screens at market cap $5.92B. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CE and PRLD stock pages for the full models.
Not investment advice.